Testosterone therapy to prevent type 2 diabetes mellitus in at‐risk men (T4DM): Design and implementation of a double‐blind randomized controlled trial
Year: 2018
Type: article
Study design: Study Protocol
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.13601
Institutions: Freemasons Foundation Centre for Men's Health, The University of Adelaide, Western Sydney University, Hudson Institute of Medical Research, The University of Sydney, National Health and Medical Research Council, Concord Repatriation General Hospital, Anzac Research Institute, University of Canberra, The University of Melbourne, Austin Hospital, The University of Queensland, Princess Alexandra Hospital, The University of Western Australia, Sir Charles Gairdner Hospital, Keogh Institute for Medical Research, Fiona Stanley Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: testosterone replacement therapy, type 2 diabetes prevention, impaired glucose tolerance, testosterone undecanoate, lifestyle intervention, Weight Watchers, overweight men, obesity, insulin resistance, glucose tolerance, sexual function, lower urinary tract symptoms, bone mineral density, telomere length, sex hormone-binding globulin, prostate-specific antigen
Open Access status: closed
OpenAlex ID: W2903987634
